H.C. Wainwright’s $33 target on ACAD

ACAD Acadia Pharmaceuticals Inc

$20.5 → $33 (+61%) by Sep 2027

Buy · lowers · said Sep 28, 2026 · 12-month default horizon

Open: judged on the close on Sep 28, 2027

The article this target came from

Acadia Pharmaceuticals stock price target lowered to $33 by H.C. Wainwright

Investing.com · Sep 28, 2026

lowered its price target on Acadia Pharmaceuticals stock (NASDAQ:ACAD) to $33 from $37

H.C. Wainwright’s track record → Acadia Pharmaceuticals Inc →

A fact about what H.C. Wainwright published, as reported by Investing.com, not a recommendation from Dalsna Finance; H.C. Wainwright is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.